Important FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
U.S. Food and Drug Administration issued a final guidance for industry titled Postapproval Pregnancy Safety Studies on May 8, 2026. The guidance provides recommendations on methodologies that can…